Using a simple blood test to track metabolism in septic shock
Part of Infections clinical trials.
This study checks if a simple blood test (the ratio of urea to creatinine) can help doctors understand changes in your metabolism during septic shock. It compares this test to a more detailed measurement of how your body uses energy. This might help guide your treatment without extra invasive procedures.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are an adult with septic shock (a severe infection that causes dangerously low blood pressure).
- You have been on a breathing machine (mechanical ventilation) for at least 3 days in a row.
- At the time you were admitted to the ICU, your kidney function was not extremely poor (creatinine level below 4.0 mg/dL).
- You do not have chronic kidney disease that requires dialysis, and you have not started dialysis while in the ICU.
- On the fourth day of being on the breathing machine, you do not need more than 70% oxygen to keep your oxygen levels stable.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how the body uses energy (metabolism) in people with septic shock. It collects information from standard monitoring during a fluid challenge (a small IV fluid test) to find patterns that might help doctors better understand and treat septic shock.
This study looks at whether a metabolite (nutrient) supplement can help the body’s cells work better when someone is in septic shock. It is done in the ICU, and it may benefit people with sepsis who still have poor circulation and high lactate levels despite standard treatment.
This trial checks if a blood test measuring renin (a kidney hormone) can help predict how severe septic shock will be and how well patients recover. It looks for early clues in ICU patients with sepsis.
This trial looks at how the immune system changes after septic shock in adults in the ICU. It may help doctors better predict or manage complications by studying blood markers a few days after starting treatment.
This trial tests a new way to measure oxygen levels in the blood of patients with septic shock. It may help doctors better understand how well the body is using oxygen.
This trial examines how the renin-angiotensin-aldosterone system (a hormone system that helps control blood pressure) changes in patients with septic shock, compared to those with sepsis without shock, cardiogenic shock, and healthy volunteers. The goal is to better understand these changes and possibly improve treatment.
Hear when a new Septic Shock trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.